MYC and cancer: With NMDAR activation amplifying CaMK II activity—which is integral to the regulation of cancer cell proliferation, differentiation, and survival—and the aberrant c-Myc functioning as a key oncogenic transcription factor that is vital for glycolysis and diverse cancer processes [100], the implications are evident.